Gland Pharma Ltd, incorporated in the year 1978, is a Small Cap company with a market cap of Rs 43408.56 Crore, operating in Pharmaceuticals sector.
Gland Pharma’s key Products/Revenue Segments include Pharmaceuticals, Sale of services and Export Incentives for the year ending 31-Mar-2020.
Investment Rationale
Gland Pharma has spent nearly two decades building up its Injectables portfolio, supported by strong manufacturing capabilities/ capacities under rigorous quality guidelines. It intends to further enhance the pipeline through efforts on peptides, long-acting injectables, suspensions, hormones, and vaccines. It enjoys superior margins with minimum financial leverage.
Financials
For the quarter ended 31-12-2020, the company has reported a Standalone Total Income of Rs 894.55 Crore. Company has reported net profit after tax of Rs 204.11 Crore in latest quarter.
